drugset / Trial / NCT05578456
Effect of Prednisone and Aspirin on IVF-ET Outcome Among Patients With Thyroid Autoimmunity
Phase 4
Not yet recruiting
540 enrolled
Second Affiliated Hospital, School of Medicine, Zhejiang University
Jiaxing Maternity and Child Health Care Hospital · collabJinhua People's Hospital · collabNingbo Women & Children's Hospital · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This trial was a 1:1 (active:placebo) randomized, double-blind, placebo-controlled trial to evaluate the safety and efficacy of prednisone and aspirin for the in vitro fertilization and embryo transfer outcome among patients with thyroid autoimmunity.
Timeline
- Start
- 2022-11-01
- Primary completion
- 2025-12-31
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | 75 mg | Oral |
| Subject | Aspirin | Small molecule | 100 mg | Oral |
| Subject | Prednisone | Other / unclassified | 10 mg | Oral |